Oncotelic Therapeutics annual revenue
2012
2013
2020
2023
Oncotelic Therapeutics Revenue Growth & History (OTLC)
Oncotelic Therapeutics reported $70,000 in revenue for fiscal 2023, a decrease of 95.98% from the previous fiscal year.
View full Oncotelic Therapeutics company overviewOncotelic Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $70,000 | −$1.7M | −95.98% |
| 2020 | 2020-12-31 | $1.7M | $1.6M | +1732.48% |
| 2013 | 2013-12-31 | $95,000 | −$61,000 | −39.10% |
| 2012 | 2012-12-31 | $156,000 | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Oncotelic Therapeutics filings at SEC.gov ↗